Lennard Lee

Associate Professor

University of Oxford

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Lennard Lee is an Associate Professor at the University of Oxford, UK. His research focuses on public dialogue related to scientific research, cancer immunotherapy, and immunocompromised patients' responses to COVID-19 vaccination. He has contributed to multiple studies and systematic reviews addressing cancer patients' safety during the pandemic and the effectiveness of vaccines in this vulnerable population.

Articles (13)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (17)

Stephen Griffin

Professor of Cancer Virology

University of Leeds

UNITED KINGDOM

Lennard Lee

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

Independent SAGE as an example of effective public dialogue on scientific research

UK cancer vaccine advance – Recognising and realising opportunities

Defining and Risk-Stratifying Immunosuppression (the DESTINIES Study): Protocol for an Electronic Delphi Study

Association of SARS-CoV-2 Spike Protein Antibody Vaccine Response With Infection Severity in Patients With Cancer: A National COVID Cancer Cross-sectional Evaluation.

Systematic review and meta‐analysis of the clinical effectiveness of tixagevimab/cilgavimab for prophylaxis of COVID‐19 in immunocompromised patients

Safe prescribing in cancer patients during the COVID-19 pandemic: A new initiative from the UK Cancer Coronavirus Project (UKCCP) team

Antibody response to a third booster dose of SARS-CoV-2 vaccination in adults with haematological and solid cancer: a systematic review

COVID-19: Third dose booster vaccine effectiveness against breakthrough coronavirus infection, hospitalisations and death in patients with cancer: A population-based study

Machine learning for determining lateral flow device results for testing of SARS-CoV-2 infection in asymptomatic populations

Mortality Among Adults With Cancer Undergoing Chemotherapy or Immunotherapy and Infected With COVID-19

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity by Viral Load, S Gene Variants and Demographic Factors, and the Utility of Lateral Flow Devices to Prevent Transmission

Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID‐19: disease control as an important factor relative to recent chemotherapy or anti‐CD20 therapy

COVID-19 in children with haematological malignancies

Collaborators (17)

Stephen Griffin

Helen Louise Robbins

Ashley Gamble

Sarah Helen ORAM

Susan Hopkins

Francesca Holt

Aris Katzourakis

Csilla Varnai

antonio pagliuca

Lucy Cook

Mohammed Altohami

Mark Middleton

Matthew Fittall

Tim Robinson

Christina Pagel

Gary Middleton

Camila Caiado

Make your next move.